RETRACTED: Correlation of IL-1F genetic polymorphisms with the risk of colorectal cancer among Chinese populations (Retracted article. See vol. 36, pg. 7325, 2015)

被引:8
作者
Ma, Ming [1 ]
Jin, Guo-Jiang [1 ]
Yun, Ke [1 ]
Mu, Run-Qing [1 ]
Zhao, Min [1 ]
Yu, Xiao-Ou [1 ]
Wang, Shuo [1 ]
Shang, Hong [1 ]
机构
[1] China Med Univ, Hosp 1, Dept Lab Med, Shenyang 110000, Peoples R China
关键词
Interleukin-17F; Colorectal cancer; Single nucleotide polymorphism; INTERLEUKIN-17A AND-17F GENES; SEQUENCE VARIANT HIS161ARG; TH17; CELLS; CYTOKINE FAMILY; ASSOCIATION; BOWEL; DISEASE; IL17F; COLON; SUSCEPTIBILITY;
D O I
10.1007/s13277-014-2653-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Inflammatory/immune cells have the power of infiltrating almost all human solid tumors and influencing all stages of carcinogenesis because of their stimulation of various cytokine subsets. This study aims to determine the correlation of single nucleotide polymorphisms in the IL-17F gene and the risk of colorectal cancer (CRC). One thousand patients diagnosed with CRC and a control group of 354 healthy controls were involved. Peripheral blood samples were collected. The PCR-RFLP method was used to detect the 7383A > G (rs2397084) and 7488T > C (rs763780) in the IL-17F gene. Statistical analyses were conducted with version 12.0 STATA statistical software. We found that the allele model suggested that patients carrying C allele were 1.67 times more likely to develop CRC than healthy controls (odds ratio (OR) = 1.67, 95 % confidence interval (CI) = 1.22-2.27, P = 0.001). Similarly, the homozygous and dominant models also revealed that the minor IL-17F 7488C allele conferred an increased CRC risk compared to the major T allele among our study participants (CC vs. TT: OR = 4.15, 95 % CI = 1.26-13.36, P = 0.011; TC+CC vs. TT: OR = 1.46, 95 % CI = 1.04-2.05, P = 0.027). However, all genetic models indicated that the IL-17F 7383A > G (rs2397084) polymorphism was not associated with CRC risk (all P > 0.05). The results of this study indicate that the 7488T > C (rs763780) in the IL-17F gene may be correlated with increased risk of CRC.
引用
收藏
页码:807 / 814
页数:8
相关论文
共 50 条
  • [31] RETRACTED: Fibroblast growth factor receptor 4 polymorphisms and the prognosis of non-Hodgkin lymphoma (Retracted article. See vol. 43, pg. 753, 2016)
    Cha, Zhanshan
    Zang, Yan
    Guo, Huijun
    Gu, Haihui
    Tu, Xiaohua
    Song, Haihan
    Qian, Baohua
    MOLECULAR BIOLOGY REPORTS, 2014, 41 (02) : 1165 - 1170
  • [32] RETRACTED: MicroRNA-375 accelerates the invasion and migration of colorectal cancer through targeting RECK (Retracted article. See vol. 27, pg. 1220, 2023)
    Wei, L. J.
    Bai, D-M
    Wang, Z-Y
    Liu, B-C
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (11) : 4738 - 4745
  • [33] RETRACTED: MicroRNA-613 targets FMNL2 and suppresses progression of colorectal cancer (Retracted article. See vol. 14, pg. 676, 2022)
    Li, Bai
    Xie, Zhongshi
    Li, Zhihong
    Chen, Si
    Li, Bo
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2016, 8 (12): : 5475 - 5484
  • [34] RETRACTED: Elevated IL-13Rα2 in Intestinal Epithelial Cells from Ulcerative Colitis or Colorectal Cancer Initiates MAPK Pathway (Retracted article. See vol. 21, pg. 1736, 2015)
    Mandal, Debasmita
    Levine, Alan D.
    INFLAMMATORY BOWEL DISEASES, 2010, 16 (05) : 753 - 764
  • [35] RETRACTED: MicroRNA-143-3p suppresses tumorigenesis by targeting catenin-δ1 in colorectal cancer (Retracted article. See vol. 16, pg. 233, 2023)
    Ding, Xiaohua
    Dui, Jiying
    Mao, Kai
    Wang, Xiaoyu
    Ding, Yuange
    Wang, Fanping
    ONCOTARGETS AND THERAPY, 2019, 12 : 3255 - 3265
  • [36] RETRACTED: LMX1A as a Prognostic Marker in Ovarian Mucinous Cystadenocarcinoma (Retracted article. See vol. 138, pg. 167, 2012)
    Lin, Chih-kung
    Chao, Tai-Kuang
    Lai, Hung-Cheng
    Lee, Herng-Sheng
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2012, 137 (06) : 971 - 977
  • [37] RETRACTED: Aberrant promoter methylation of RASSF1A gene may be correlated with colorectal carcinogenesis: a meta-analysis (Retracted article. See vol. 42, pg. 1455, 2015)
    Wang, He-Ling
    Zhang, Yu
    Liu, Peng
    Zhou, Ping-Yi
    MOLECULAR BIOLOGY REPORTS, 2014, 41 (06) : 3991 - 3999
  • [38] RETRACTED: Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma (Retracted article. See vol. 18, pg. 1270, 2019)
    Shraibman, Bracha
    Barnea, Eilon
    Kadosh, Dganit Melamed
    Haimovich, Yael
    Slobodin, Gleb
    Rosner, Itzhak
    Lopez-Larrea, Carlos
    Hilf, Norbert
    Kuttruff, Sabrina
    Song, Colette
    Britten, Cedrik
    Castle, John
    Kreiter, Sebastian
    Frenzel, Katrin
    Tatagiba, Marcos
    Tabatabai, Ghazaleh
    Dietrich, Pierre-Yves
    Dutoit, Valerie
    Wick, Wolfgang
    Platten, Michael
    Winkler, Frank
    von Deimling, Andreas
    Kroep, Judith
    Sahuquillo, Juan
    Martinez-Ricarte, Francisco
    Rodon, Jordi
    Lassen, Ulrik
    Ottensmeier, Christian
    van der Burg, Sjoerd H.
    Thor Straten, Per
    Poulsen, Hans Skovgaard
    Ponsati, Berta
    Okada, Hideho
    Rammensee, Hans-Georg
    Sahin, Ugur
    Singh, Harpreet
    Admon, Arie
    MOLECULAR & CELLULAR PROTEOMICS, 2018, 17 (11) : 2132 - 2145
  • [39] RETRACTED: Fibroblast Growth Factor Receptor 4 Polymorphisms Are Associated with Coronary Artery Disease (Retracted article. See vol. 20, pg. 162, 2016)
    Chen, Hao
    Tong, Jiabin
    Zou, Tong
    Shi, Haifeng
    Liu, Junpeng
    Du, Xin
    Yang, Jiefu
    Ma, Changshen
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2012, 16 (08) : 952 - 956
  • [40] RETRACTED: Calcium Channel Blockers and Risk of Breast Cancer: A Meta-Analysis of 17 Observational Studies (Retracted article. See vol. 13, pg. 2018)
    Li, Wen
    Shi, Qi
    Wang, Weibing
    Liu, Jianrong
    Li, Qi
    Hou, Fenggang
    PLOS ONE, 2014, 9 (09):